Treatments that target a fragment of the mutant protein that causes Huntington's disease might be more effective than ...
NANJING, China, Nov. 10, 2025 /PRNewswire/ -- Simcere Pharmaceutical Group (2096.HK) announced that its regulatory T cells（Treg）-preferential IL-2 mutant Fc fusion protein (IL-2 mu-Fc), SIM0278, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results